Does levetiracetam (Keppra) reduce vitamin B levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Keppra Lower Vitamin B Levels?

No, levetiracetam (Keppra) does not lower vitamin B levels. Unlike older enzyme-inducing antiepileptic drugs, levetiracetam has no significant effect on vitamin B12, folate, or vitamin B6 status.

Evidence from Clinical Studies

The most direct evidence comes from a controlled study specifically examining this question. Research demonstrates that levetiracetam monotherapy does not affect serum concentrations of homocysteine, vitamin B12, or folate 1. This study compared 33 patients on levetiracetam for at least 6 months with 35 controls and found no statistically significant differences in any B-vitamin markers.

Contrast with Enzyme-Inducing Antiepileptic Drugs

This finding is particularly important when contrasted with older antiepileptic medications. Enzyme-inducing AEDs like phenytoin and carbamazepine commonly cause vitamin B6 deficiency—occurring in 48% of patients taking these medications 2. When patients were switched from enzyme-inducing AEDs to non-inducing drugs (including levetiracetam), vitamin B6 deficiency dropped from 48% to only 21%.

The key distinction is that levetiracetam is not an enzyme inducer. The FDA label confirms that levetiracetam and its metabolites are neither inhibitors of, nor high affinity substrates for, human liver cytochrome P450 isoforms, epoxide hydrolase, or UDP-glucuronidation enzymes 3. This lack of enzyme induction explains why it doesn't interfere with vitamin metabolism.

Clinical Implications

  • No routine B-vitamin supplementation is needed for patients on levetiracetam monotherapy based solely on the medication
  • Patients switching from older enzyme-inducing AEDs to levetiracetam may actually see improvement in their B-vitamin status
  • If B-vitamin deficiency is present in a patient on levetiracetam, look for other causes (dietary insufficiency, malabsorption, other medications like metformin or proton pump inhibitors)

Special Consideration: Pyridoxine for Behavioral Side Effects

While levetiracetam doesn't cause vitamin B deficiency, there is emerging evidence that pyridoxine (vitamin B6) supplementation may help reduce neuropsychiatric adverse events associated with levetiracetam in pediatric patients 4. A recent randomized controlled trial showed significantly greater behavioral improvement with pyridoxine supplementation (10 mg/kg/day, maximum 200 mg) compared to placebo. However, this represents treatment of a side effect rather than correction of a deficiency.

Bottom Line

Levetiracetam is safe from a vitamin B perspective and does not require monitoring or supplementation of B vitamins 1. This represents a significant advantage over older enzyme-inducing antiepileptic drugs and should reassure clinicians and patients about long-term use.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.